Fabien Wuestenberghs MD PhD MSc

Gastroenterologist @HopitalAvicenne. Asst. Prof. @univ_sp. Clinician-scientist in #DGBI & #motility disorders. @AgroParisTech #PNCA. RT≠endorse. Views=mine.

[John Damianos, M.D. @john_damianosMD]

Patients with disorders of gut-brain interaction have abnormal antroduodenal motility.

#MedTwitter #GITwitter #motility

https://t.co/M15d3xnZVR

[Fabien Wuestenberghs MD PhD MSc @wuefab]

#Ebastine 20mg o.d. is superior to placebo on the intensity of abdominal #pain in pts with “non-constipated” #IBS and well tolerated (phase 2b RCT). Awaiting the results of the phase 3 study evaluating higher dose (40mg/d) against mebeverine. https://t.co/VrxrgBuB5y @Gut_BMJ

[Marcus Böhme @BoehmeMarcus]

Psychosocial stress-induced intestinal permeability in healthy humans: What is the evidence?

Excellent review by @daniquelatorre @labgas_kuleuven @VanuytselTim @DigaLab

https://t.co/1xPgfYhB21

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

What makes people with #IBS satisfied 😇 with their life? Almost 30% unsatisfied. Yet apparently, not the severity of GI symptoms 😖, rather mental quality of life was strongly associated with satisfaction with life.

@AmCollegeGastro @AmJGastro #GItwitter
https://t.co/u7zN1QAKhz

[IBSResearch @ibs_research]

Exploring new subgroups for irritable bowel syndrome using a machine learning algorithm #IBS #DGBI #GITwitter
https://t.co/i0SoT9PoaB

[Neurogastro & Motil @NGMJournal]

✅Patients with #InterstitialLungDisease generates⬆️ #TransDiaphragmatic pressure & ⬇️ #EsophagoGastricJunction pressure & have ⬆️incidence of #HiatalHernia ▶️Explain the⬆️ prevalence of #GERD in #ILD👏 @NGMJournal🔥
👉https://t.co/ZgtvyaPHJd
@ANMSociety @esnm_eu #GITwitter

[Alexander Ford @alex_ford12399]

Delighted to announce that the @AtlantisTrial of low-dose titrated amitriptyline as a second-line treatment for #IBS in primary care is now published online in @TheLancet

https://t.co/CzLSNkEHtj

I will be presenting the results today at 1430hrs at #UEGWeek2023

[AJP-Gastrointestinal and Liver Physiology @ajpgi]

🔓 this study aimed to determine if the composition of mucosal microbiota differed between IBS, or IBS bowel habit (BH) subtypes, and healthy controls (HCs).

🖱https://t.co/ypWz32gNFg

@TienDongMD @LinChangMD #IrritableBowelSyndrome #ColonicMucosalMicrobiota #PrevotellaCopri

[Inês Trindade @inesatrindade]

Fresh off the press: Check our pre-proof manuscript in @AmJGastro about the global prevalence of psychological distress and the overlap with DGBI, in a global sample of over 54k adults from the @RomeFoundation @RomeResearch

https://t.co/mrSmC8aU9S

[Neurogastro & Motil @NGMJournal]

🆕@NGMJournal🔥
👉https://t.co/ovl2w6htCG
✅~90% of patients with #FunctionalDyspepsia have trialed #RestrictiveDiets
✅The dyspepsia group had poorer #QOL & greater #GI #SymptomSeverity
@tuck_caroline @jrbiesiekierski...👏
@ANMSociety @esnm_eu #GITwitter #MedTwitter

[Daniel Keszthelyi MD PhD RFF @IBS_Maastricht]

When to refer #IBS patients to digital behavioural gut-brain therapies?

@dbrennerGIMD & @DrKinsinger give you the answer in @AGA_CGH

#GItwitter
🔓https://t.co/MFIVrjir7W

[Fabien Wuestenberghs MD PhD MSc @wuefab]

Faecal #microbiota transplantation for #IrritableBowelSyndrome with #diarrhoea doesn't reduce the severity of the disorder: https://t.co/cpj29Siw9f in @APandT. Improvement of #bloating was associated with a reduction in SH2-producing bacteria. #FMT #IBS #DGBI

[Kewin Siah @KewinSiah]

😴 Poor sleep quality was linked to higher next-day abdominal pain and lower GI symptoms in 80 IBS patients. 66% had sleep disturbances, and 82% screened positive for sleep disorders, mainly insomnia. #Gitweeter #IBS #SleepStudy 🌙💤

https://t.co/Da8yUacPjf

[Pierfrancesco Visaggi, MD @Pierfra_Visaggi]

Lyon 2.0 is out now!!!!
So exciting to see that our work (link in the comments) demonstrating that Los Angeles grade B esophagitis provides objective #GERD evidence updated the way we will diagnose GERD from now on!
https://t.co/GeQ9tXTakk

[roypounder.apt @APandT]

Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors - read at https://t.co/HFLXj2M3yQ (Open Access) . #IBD #GITwitter

[John Damianos, M.D. @john_damianosMD]

The diagnosis of #gastroparesis is incorrect 80% of the time.

#MedTwitter #GITwitter #motility

https://t.co/8K4tS4jZff

[Ali Rezaie MD MSc @AliRezaieMD]

Managing IBD/IBS overlap can be a real challenge.

As someone who has done advanced fellowships in both IBD and GI Motility, I know how hard it can be to keep up with these rapidly-evolving fields.

Highly recommend our practical guide @GIJANE_MD to help you navigate IBD/IBS overlap.
https://t.co/DucSoSJMbi

[Fabien Wuestenberghs MD PhD MSc @wuefab]

Spotlight on #IrritableBowelSyndrome this week in @lemonde_science, highlighting our integred care model @HopitalAvicenne (@APHP @univ_spn). Thanks to Pauline, Noémie, Nicolas and especially Jean-Marc for this achievement. Find out more: https://t.co/SiHqaTodHh #IBS #DGBI

[Le Monde Sciences @lemonde_science]

A l’hôpital Avicenne, à Bobigny, un dispositif original de prise en charge du syndrome de l’intestin irritable https://t.co/oFaeOGvkRu

[Melchior Chloé @MelchiorChloe]

Role of diet in IBS by #SannaNybacka #neurogastromeeting2023. Nice guidelines should be in the 1st line and you should rule out disorders eating, including #ARFID.